AusCann has not had a permanent CEO since September.

AusCann buys Perth R&D site for $5.3m

AusCann Group Holdings has acquired a 7,300 square metre research and development facility in Perth for $5.25 million


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/12/19

1 year TSR5 year TSR
138thBARD1 Life Sciences56%8%
410thRBR Group-0%-7%
735thAusCann Group Holdings-53%48%
668 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

$11k Bought
$47k Bought
$15k Issued
Total value as at the date of the transaction
Powered by Morningstar ®


151st↑AusCann Group Holdings$671k
153rd↑BARD1 Life Sciences$571k
154th↓RBR Group$530k
156th↑Sky and Space Global$503k
157th↓JV Global$487k
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®